###begin article-title 0
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
Association Testing of Novel Type 2 Diabetes Risk Alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With Insulin Release, Insulin Sensitivity, and Obesity in a Population-Based Sample of 4,516 Glucose-Tolerant Middle-Aged Danes
###end article-title 0
###begin p 1
###xml 36 49 36 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">ngrp@steno.dk</email>
Corresponding author: Niels Grarup, ngrp@steno.dk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMTS9</italic>
###xml 244 250 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
OBJECTIVE- We evaluated the impact on diabetes-related intermediary traits of common novel type 2 diabetes-associated variants in the JAZF1 (rs864745), CDC123/CAMK1D (rs12779790), TSPAN8 (rs7961581), THADA (rs7578597), ADAMTS9 (rs4607103), and NOTCH2 (rs10923931) loci, which were recently identified by meta-analysis of genome-wide association data.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
RESEARCH DESIGN AND METHODS- We genotyped the six variants in 4,516 middle-aged glucose-tolerant individuals of the population-based Inter99 cohort who were all characterized by an oral glucose tolerance test (OGTT).
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 402 404 402 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 591 597 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 890 897 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 902 908 902 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
RESULTS- Homozygous carriers of the minor diabetes risk G-allele of the CDC123/CAMK1D rs12779790 showed an 18% decrease in insulinogenic index (95% CI 10-27%; P = 4 x 10-5), an 18% decrease in corrected insulin response (CIR) (8.1-29%; P = 4 x 10-4), and a 13% decrease in the ratio of area under the serum-insulin and plasma-glucose curves during an OGTT (AUC-insulin/AUC-glucose) (5.8-20%; P = 4 x 10-4). Carriers of the diabetes-associated T-allele of JAZF1 rs864745 had an allele-dependent 3% decrease in BIGTT-AIR (0.9-4.3%; P = 0.003). Furthermore, the diabetes-associated C-allele of TSPAN8 rs7961581 associated with decreased levels of CIR (4.5% [0.5-8.4]; P = 0.03), of AUC-insulin/AUC-glucose ratio (3.9% [1.2-6.7]; P = 0.005), and of the insulinogenic index (5.2% [1.9-8.6]; P = 0.002). No association with traits of insulin release or insulin action was observed for the THADA, ADAMTS9, or NOTCH2 variants.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
CONCLUSIONS- If replicated, our data suggest that type 2 diabetes at-risk alleles in the JAZF1, CDC123/CAMK1D, and TSPAN8 loci associate with various OGTT-based surrogate measures of insulin release, emphasizing the contribution of abnormal pancreatic beta-cell function in the pathogenesis of type 2 diabetes.
###end p 6
###begin p 7
Published ahead of print at  on 20 June 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 560 566 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 568 574 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
Recent discoveries using genome-wide association (GWA) studies have led to progression in the understanding of the molecular genetic background of type 2 diabetes, dramatically increasing the number of common validated type 2 diabetes loci with modest impact on relative diabetes risk (1-5). The Diabetes Genetics Replication and Meta-analysis (DIAGRAM) consortium recently reported the outcome of a meta-analysis of data from three GWA studies. Six additional type 2 diabetes loci reaching genome-wide significance levels were identified in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci; all were modestly affecting disease risk with odds ratios between 1.09 and 1.15 (6).
###end p 9
###begin p 10
###xml 365 371 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 373 380 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 382 386 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 387 390 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDE</italic>
###xml 392 398 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A</italic>
###xml 399 401 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2B</italic>
###xml 403 410 400 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 412 418 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 424 430 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 437 438 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 439 440 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 441 442 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 462 467 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 581 583 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 601 604 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 637 639 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 681 682 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 712 718 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 834 836 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 976 981 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 983 989 977 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 990 996 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 998 1004 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 1006 1011 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 1016 1023 1010 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
As for most other findings obtained from GWA studies, little is known about the function of the putative regional candidate genes thought to be affected by the at-risk variants. Recent studies have, however, shown that many validated type 2 diabetes risk variants confer an impaired pancreatic beta-cell function, which seems to be the case for risk alleles in the CDKAL1, SLC30A8, HHEX/IDE, CDKN2A/2B, IGF2BP2, TCF7L2, and KCNJ11 loci (2,7-9). Indeed, only the PPARG Pro12Ala variant has so far displayed a diabetogenic potential through affecting peripheral insulin sensitivity (10) and variants in FTO by increasing fat accumulation (11). Of the six novel type 2 diabetes loci (6), the biological function of NOTCH2 points to an impact on pancreatic beta-cell function because of its critical role in fetal pancreatic development (12), yet little or no prior implication in the pathogenesis of type 2 diabetes or diabetes-related phenotypes can be claimed for genes in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, or ADAMTS9 regions.
###end p 10
###begin p 11
Given the sparse knowledge of the biological functions of the six novel type 2 diabetes-associated variants, we have characterized the influence of these variants on quantitative surrogate measures of oral glucose-stimulated insulin release, insulin sensitivity, and body fat accumulation in a population-based study of glucose-tolerant middle-aged Danes who all had undertaken an oral glucose tolerance test (OGTT).
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 689 690 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 752 753 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 982 983 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 392 404 <span type="species:ncbi:9606">participants</span>
###xml 917 920 <span type="species:ncbi:9606">men</span>
###xml 927 932 <span type="species:ncbi:9606">women</span>
Studies of quantitative metabolic traits were performed in the Inter99 cohort, which is a population-based, randomized, nonpharmacological intervention study of 6,784 middle-aged subjects for the prevention of ischemic heart disease, conducted at the Research Centre for Prevention and Health in Glostrup, Copenhagen (ClinicalTrials.gov ID-no: NCT00289237) (13). An OGTT was performed in all participants with measurements of plasma glucose and serum insulin at fasting and at 30 and 120 min, and 6,083 subjects with available DNA were subsequently classified as individuals with normal glucose tolerance (NGT) (n = 4,516), impaired fasting glycemia (n = 503), impaired glucose tolerance (n = 692), screen-detected and treatment-naive type 2 diabetes (n = 253), or previously diagnosed type 2 diabetes (n = 119). In the analysis of quantitative diabetes-related phenotypes, we included 4,516 subjects with NGT (2,101 men/2,415 women, age 45.2 +/- 7.9 years and BMI 25.5 +/- 4.1 kg/m2 [mean +/- SD]). Type 2 diabetes was diagnosed according to World Health Organization 1999 criteria.
###end p 13
###begin p 14
###xml 47 59 <span type="species:ncbi:9606">participants</span>
Informed written consent was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki II and was approved by the local ethics committee of Copenhagen.
###end p 14
###begin title 15
Biochemical and anthropometrical measures.
###end title 15
###begin p 16
Height and weight were measured in light indoor clothing and without shoes. Waist circumference was measured in the upright position midway between the iliac crest and the lower costal margin. Blood samples were drawn after a 12-h overnight fast. Plasma glucose was analyzed by a glucose oxidase method (Granutest; Merck, Darmstadt, Germany). Serum insulin [excluding des (31,32)] and intact proinsulin) was measured using the AutoDELFIA insulin kit (Perkin-Elmer, Wallac, Turku, Finland).
###end p 16
###begin title 17
Indexes of insulin release and insulin sensitivity.
###end title 17
###begin p 18
###xml 354 360 354 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 376 381 376 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 min</sub>
###xml 406 412 406 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 473 479 473 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 495 501 495 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 519 525 519 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 730 735 730 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 min</sub>
###xml 760 765 760 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 min</sub>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 813 814 813 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 814 815 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 962 963 962 963 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1276 1277 1276 1277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
Oral glucose-stimulated insulin release was reported as the insulinogenic index, the corrected insulin response (CIR), the ratio of the area under the curve (AUC) of insulin to the AUC of glucose during the OGTT (AUC-insulin/AUC-glucose), and the BIGTT-acute insulin response (AIR) index. The insulinogenic index was calculated as follows: (serum insulin30 min - serum insulin0 min [pmol/l])/plasma glucose30 min [mmol/l]. CIR was calculated as follows: 100 x serum insulin30 min/[plasma glucose30 min x (plasma glucose30 min - 3.89)] (14). Indexes of insulin sensitivity were reported as the insulin sensitivity index (ISI), calculated as the reciprocal of homeostasis model assessment of insulin resistance {22.5/[plasma glucose0 min (mmol/l) x serum insulin0 min (pmol/l)]} (15), and as the OGTT-derived BIGTT-SI. The BIGTT indexes apply information on sex and BMI combined with plasma glucose and serum insulin during an OGTT to provide indexes for AIR and SI that are highly correlated with indexes obtained during an intravenous glucose tolerance test and were calculated as reported (16). To construct OGTT-based disposition indexes, we multiplied the CIR index with ISI, since these measures are not intrinsically interdependent. Furthermore, we multiplied the BIGTT-SI index with the BIGTT-AIR index.
###end p 18
###begin title 19
Genotyping.
###end title 19
###begin p 20
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The six gene variants (rs864745, rs12779790, rs7961581, rs7578597, rs4607103, and rs10923931) were genotyped by TaqMan allelic discrimination (KBiosciences, Hoddesdon, U.K). All genotyping success rates were above 96% and all mismatch rates were below 1% in 1,090 duplicate samples. The distributions of genotypes for all variants were in the Hardy-Weinberg equilibrium (all P > 0.05).
###end p 20
###begin title 21
Statistical analysis.
###end title 21
###begin p 22
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 639 640 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 744 745 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
A general linear statistical methodology was used to test quantitative traits in relation to genotype, applying additive, dominant, and recessive models while adjusting for the effect of age (BIGTT-SI and BIGTT-AIR), age and sex (BMI and waist), or age, sex, and BMI (all other traits). BMI and all values of plasma glucose and serum insulin and derived indexes of insulin release and insulin sensitivity were logarithmically transformed before analysis. In the main text, parameter estimates (95% CI) of associated quantitative traits are given, while data in tables are unadjusted medians or means. The multivariate method, Hotelling's T2, was applied to test the simultaneous effect of genotype on insulin release and insulin sensitivity. A P value of <0.05 was considered significant. All analyses were performed using RGui, version 2.6.1 ().
###end p 22
###begin title 23
Estimation of statistical power.
###end title 23
###begin p 24
Statistical power for the quantitative traits was estimated using simulations. We assumed an additive genetic model for both the simulation of the data and for testing the data using a linear model. We used the empirical variance of the observed traits to simulate phenotypes from a normal distribution so that variance across genotypes is drawn from the estimated variance. Because we also include adjustment factors in our analysis, we estimated the variance from the residuals of a linear model containing the adjustment factors. Thus, we assume that the genotype and the adjustment factors are independent. The power was estimated using 5,000 simulations and a significance threshold of 0.05. Based on the allele frequencies of the six examined gene variants and a sample size of 4,516 subjects, we estimated the effect sizes per allele of quantitative traits for which we had 80 and 90% statistical power, respectively, to detect an association. Depending on allele frequency (range 9.5-48.0%) and assuming an additive model, we had 80% power to detect an allele-dependent difference of 0.8-1.4% in BMI, 2.2-3.8% in BIGTT-AIR, 3.2-5.4% in insulinogenic index, and 3.0-5.0% in ISI. Similarly, we had 90% statistical power to detect a 1.0-1.7% change per allele in BMI, 2.6-4.3% in BIGTT-AIR, 3.7-6.2% in insulinogenic index, and 3.4-5.9% in ISI, respectively.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin p 26
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMTS9</italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 498 499 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 531 532 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 685 692 685 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 758 764 758 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 765 771 765 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 855 856 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 865 867 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 926 928 926 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 962 963 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 972 974 972 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1031 1032 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1041 1043 1041 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1046 1053 1046 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 1136 1142 1136 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 1243 1244 1243 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1290 1291 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1356 1357 1356 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1423 1424 1423 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1435 1442 1435 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
We investigated the JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, and NOTCH2 rs10923931 variants for association with type 2 diabetes-related quantitative traits in a population-based sample of 4,516 glucose-tolerant subjects. Assuming an additive genetic model, carriers of the major diabetes-associated T-allele of JAZF1 rs864745 had a 0.21 kg/m2 decreased BMI (0.048-0.39 kg/m2; P = 0.02), a 0.47 cm decreased waist circumference (0.03-0.90 cm; P = 0.04), and a 2.6% (0.9-4.3%; P = 0.003) decreased insulin release per allele as assessed by the BIGTT-AIR index. The variant did not associate with other measures of insulin release (Table 1). Homozygous carriers of the minor diabetes risk G-allele of the CDC123/CAMK1D rs12779790 showed a 15% decreased serum insulin at 30 min during an OGTT (7.8-23%, P = 8 x 10-5), an 18% decreased insulinogenic index (10-27%; P = 4 x 10-5), an 18% decreased CIR (8.1-29%; P = 4 x 10-4), and a 13% decreased AUC-insulin/AUC-glucose (5.8-20%; P = 4 x 10-4) (Table 2). When applying a dominant genetic model, the minor diabetes risk C-allele of the TSPAN8 rs7961581 associated with a modest decrease in serum insulin at 30 min during OGTT (4.9% [1.9-7.9]; P = 0.001), a decrease in CIR (4.5% [0.5-8.4]; P = 0.03), a decrease in AUC-insulin/AUC-glucose (3.9% [1.2-6.7]; P = 0.005), and a decrease in insulinogenic index (5.2% [1.9-8.6]; P = 0.002) (Table 3).
###end p 26
###begin p 27
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMTS9</italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 424 425 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 448 449 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The THADA rs7578597 did not associate with measures of obesity (BMI: P = 0.4), insulin response (insulinogenic index: P = 0.4), or insulin sensitivity (BIGTT-SI: P = 1) (Supplementary Table 1 [available in an online appendix at ]). Similarly, the ADAMTS9 rs4607103 and NOTCH2 rs10923931 variants did not significantly associate with measures of oral glucose-stimulated insulin response (all P >/= 0.5), insulin sensitivity (P >/= 0.1), or obesity (P >/= 0.1) in the Inter99 cohort (Supplementary Tables 2 and 3). Similar results were found when including all 5,964 treatment-naive individuals from the Inter99 cohort (data not shown).
###end p 27
###begin p 28
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 311 317 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 511 512 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 695 701 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 731 732 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Because the insulin response to glucose is highly dependent on the level of insulin sensitivity, we constructed two OGTT-based disposition indexes by combining existing indexes of insulin response and insulin sensitivity and tested association with the six genotyped variants. Homozygous carriers of the CDC123/CAMK1D diabetes-associated G-allele showed a nominal association with a 13% decrease in a disposition index based on CIR and ISI (1.1-24%; P = 0.03). A disposition index based on BIGTT-AIR and BIGTT-SI did, however, not differ significantly between genotype groups for any of the six variants, although a tendency toward an allele-dependent decrease in minor G-allele carriers of the CDC123/CAMK1D variant was observed (P = 0.05).
###end p 28
###begin p 29
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 315 316 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 318 324 318 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 419 425 419 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 473 481 473 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ADDITIVE</sub>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 494 503 494 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">RECESSIVE</sub>
###xml 585 591 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 602 610 602 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DOMINANT</sub>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 623 632 623 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink">RECESSIVE</sub>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 750 751 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
To further evaluate the relationship between insulin release, insulin sensitivity, and genetic predispositions of the type 2 diabetes-associated variants, we applied the multivariate Hotelling's T2 method to simultaneously test the effect of genotype on a combination of CIR and ISI as well as BIGTT-AIR and BIGTT-SI (Fig. 1). We demonstrated statistically significant multivariate associations of the JAZF1 and CDC123/CAMK1D variants with the combination of CIR and ISI (PADDITIVE = 0.04 and PRECESSIVE = 0.002, respectively). Furthermore, borderline association was observed for the TSPAN8 variant (PDOMINANT = 0.09 and PRECESSIVE = 0.05). The multivariate analysis did not show any influence of genotype on the combination of BIGTT-AIR and BIGTT-SI (data not shown).
###end p 29
###begin title 30
DISCUSSION
###end title 30
###begin p 31
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 316 321 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 323 329 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 330 336 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 342 348 339 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 489 495 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 496 502 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 507 513 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 632 637 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 642 648 636 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 649 655 643 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 940 941 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
We report the association testing of six recently discovered type 2 diabetes risk variants (6) with intermediary diabetes-related phenotypes. Our results, if replicated in independent and statistically well-powered studies, suggest an impairment of pancreatic beta-cell function for diabetes risk alleles in or near JAZF1, CDC123/CAMK1D, and TSPAN8, since these variants were associated with various surrogate measures of insulin release during an OGTT. Further support of the role of the CDC123/CAMK1D and TSPAN8 variants in altered pancreatic beta-cell function was provided when analyzing an OGTT-based disposition index and for JAZF1 and CDC123/CAMK1D variants when doing multivariate analysis of estimates of insulin sensitivity and insulin release. The observed associations for all three variants are concordant with an impaired oral glucose-stimulated insulin release in subjects carrying the reported type 2 diabetes risk alleles (6).
###end p 31
###begin p 32
In the analyses, we primarily focused on glucose-tolerant subjects to avoid the confounding influence of disturbances in glucose homeostasis and to circumvent the risk that associations with especially impaired insulin response were driven by the known association with type 2 diabetes. We did, however, observe similar results when including subjects with impaired fasting glycemia, impaired glucose tolerance, or screen-detected type 2 diabetes.
###end p 32
###begin p 33
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2C2</italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2C2</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr2c2</italic>
###xml 379 380 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PEPCK</italic>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 623 628 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 659 661 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 719 724 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 392 396 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
rs864745 resides in intron 1 of the JAZF1 (juxtaposed with another zinc finger gene 1) gene, which encodes a transcriptional repressor of the nuclear receptor subfamily 2, group C, member 2 (NR2C2) gene (17). NR2C2 (also known as TR4) is a member of the nuclear hormone receptor family and acts as a ligand-activated transcription factor (18). NR2C2 is widely expressed and Nr2c2-/- knockout mice display a phenotype of growth retardation, hypoglycemia, and reduced gluconeogenesis by decreased activation of PEPCK (19,20); however, no obvious involvement in pancreatic beta-cell function has been demonstrated. Yet, since JAZF1 is expressed in the pancreas (17), one might speculate that a gain-of-function variant in JAZF1 may lead to postnatal growth restriction also affecting pancreatic beta-cell mass and function.
###end p 33
###begin p 34
###xml 46 52 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 83 97 59 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D. CDC123</italic>
###xml 132 145 108 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 302 304 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 315 321 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 408 410 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 487 493 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 132 145 <span type="species:ncbi:4932">S. cerevisiae</span>
rs12779790 is located approximately90 kb from CDC123 and approximately63.5 kb from CAMK1D. CDC123 (cell division cycle 123 homolog [S. cerevisiae]) encodes a protein involved in cell cycle regulation and nutritional control of gene transcription with no known relation to type 2 diabetes pathogenesis (21). Because CAMK1D (calcium/calmodulin-dependent protein kinase I delta) regulates granulocyte function (22), it is also possible that a causative variant in this region is related to CAMK1D and affects pancreatic beta-cell function through increased apoptosis.
###end p 34
###begin p 35
###xml 58 64 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 228 230 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 351 353 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 389 395 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
Lastly, rs7961581 resides approximately110 kb upstream of TSPAN8 (tetraspanin 8), which encodes a widely expressed cell surface glycoprotein known to form complexes with integrins to regulate cell motility in cancer cell lines (23). Because alpha6-integrin binding to laminin has been shown to negatively affect pancreatic beta-cell mass maintenance (24), it is possible that variation in TSPAN8 biologically influences pancreatic beta-cell function.
###end p 35
###begin p 36
###xml 318 324 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 325 331 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 336 342 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 540 542 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 543 545 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 601 603 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 639 644 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
In this article, we have performed a thorough evaluation of a range of OGTT-based surrogate estimates of insulin release and insulin sensitivity. The associations of examined gene variants to various measures of pancreatic beta-cell function highlight the need for cautious interpretation of outcomes. Variants in the CDC123/CAMK1D and TSPAN8 regions associate with the insulinogenic index, the corrected insulin response, and the ratio of AUC-insulin to AUC-glucose, which are widely used and well-documented estimates of insulin release (25,26), yet not with the recently described BIGTT-AIR index (16), and the opposite is true for the JAZF1 variant. These discrepancies may be caused by different accuracy and/or sensitivity of the applied surrogate indexes or the possibility that the different indexes capture particular and diverse roles of the encoded proteins in specific steps of insulin biosynthesis, insulin secretion, or insulin elimination. However, we cannot exclude that the associations to various measures are caused by statistical type I or II errors. Although we analyzed a range of OGTT-based surrogate indexes of insulin release, we acknowledge that application of more precise measures of insulin release, such as estimates based on an intravenous glucose tolerance test, may have modified the outcome of our analyses.
###end p 36
###begin p 37
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 474 481 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
Type 2 diabetes-associated variants in the THADA, ADAMTS9, and NOTCH2 loci did not associate with metabolic traits in the Inter99 cohort. Lack of statistical power is a possible explanation, since these variants confer a modestly increased risk of type 2 diabetes. Based on 95% CIs of effect size estimates, we can with confidence exclude an allele-dependent effect in the current study on BMI, insulinogenic index, BIGTT-AIR, and ISI above 4.5% for THADA rs7578597, 3% for ADAMTS9 rs4607103, and 4% for NOTCH2 rs10923931. However, we are unable to estimate potential associations below these effect sizes.
###end p 37
###begin p 38
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 749 754 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 797 803 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 804 810 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 870 876 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
We recognize that since no correction for multiple hypothesis testing was applied, the present results are of an explorative nature and call for validation in statistically powered and well-characterized cohorts. If, however, stringent Bonferroni correction for multiple testing (252 tests) was performed, only the associations of the CDC123/CAMK1D rs12779790 variant with measures of insulin response (insulinogenic index and serum insulin at 30 min during the OGTT) would remain statistically significant, underlining the need for replication. Based on the effect sizes of the current study, we estimate that approximately3,300, 6,100, and 3,900 subjects are needed for future studies to achieve 80% statistical power to replicate associations of JAZF1 rs864745 with BIGTT-AIR (additive model), CDC123/CAMK1D rs12779790 with insulinogenic index (recessive model), and TSPAN8 rs7961581 with insulinogenic index (dominant model), respectively.
###end p 38
###begin p 39
###xml 157 162 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 164 170 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 171 177 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 183 189 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 237 242 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THADA</italic>
###xml 244 251 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAMTS9</italic>
###xml 257 263 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 377 383 <span type="species:ncbi:9606">people</span>
In conclusion, we report data suggesting an impaired pancreatic beta-cell function in glucose-tolerant carriers of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, and TSPAN8 regions. No associations of common variants in THADA, ADAMTS9, and NOTCH2 with quantitative measures of insulin release or insulin sensitivity could be shown in the cohort of middle-aged people.
###end p 39
###begin title 40
Supplementary Material
###end title 40
###begin title 41
Online-Only Appendix
###end title 41
###begin p 42
The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); the Danish Health Research Council, The European Union (EUGENE2, grant no. LSHM-CT-2004-512013), Danish Council for Strategic Research (DanORC, grant no. 2101-06-0005), the Faculty of Health Sciences of Aarhus University, the Danish Clinical Intervention Research Academy, and the Danish Diabetes Association and Novo Nordisk.
###end p 42
###begin p 43
We are thankful to Dr. Mark McCarthy, Dr. Michael Boehnke, Dr. David Altshuler, Dr. Leif Groop, and Dr. Francis Collins from the DIAGRAM consortium for prepublication information on the identity of novel type 2 diabetes genes and loci. The authors thank A. Forman, I.-L. Wantzin, and M. Stendal for technical assistance and G. Lademann for secretarial support.
###end p 43
###begin p 44
We acknowledge all the members of the Inter99 team. The steering committee of the Inter99 study comprises: T. Jorgensen (principal investigator [PI]), K. Borch-Johnsen (co-PI), H. Ibsen, T. Thomsen, C. Pisinger, and C. Glumer. The study was financially supported by The Danish Medical Research Council, The Danish Centre for Health Technology Assessment, Novo Nordisk, Research Foundation of Copenhagen County, Ministry of Internal Affairs and Health, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation, The Ib Henriksen Foundation, and The Becket Foundation.
###end p 44
###begin title 45
REFERENCES
###end title 45
###begin p 46
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 567 568 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
###xml 741 747 741 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 748 754 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 768 776 768 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ADDITIVE</sub>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 789 798 789 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">RECESSIVE</sub>
###xml 876 882 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
###xml 894 895 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 895 903 895 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DOMINANT</sub>
###xml 915 916 915 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 916 925 916 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink">RECESSIVE</sub>
###xml 330 338 <span type="species:ncbi:301928">ellipses</span>
Two-dimensional standard error of the mean of logarithm of the ISI and logarithm of CIR stratified according to genotype of JAZF1 rs864745, CDC123/CAMK1D rs12779790, and TSPAN8 rs7961581 in 4,516 subjects from the Inter99 cohort with normal glucose tolerance. Assuming bivariate normal distribution, we constructed standard error ellipses around the means of each genotype level. Numbers of subjects are: rs864745: TT: 1,039, TC: 2,020, CC: 898; rs12779790: AA: 2,588, AG: 1,229, GG: 153; rs7961581: TT: 2,181, TC: 1,518, CC: 289. The multivariate method, Hotelling T2, was applied to test the simultaneous effect of genotype on the two traits of insulin release and insulin sensitivity, and association was found for the JAZF1 rs864745 and CDC123/CAMK1D rs12779790 (PADDITIVE = 0.04 and PRECESSIVE = 0.002, respectively). Furthermore, borderline association was observed for TSPAN8 rs7961581 (PDOMINANT = 0.09 and PRECESSIVE = 0.05).
###end p 46
###begin p 47
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAZF1</italic>
Unadjusted quantitative metabolic traits in the population-based Inter99 cohort including 4,377 middle-aged subjects with normal glucose tolerance stratified according to genotype of JAZF1 rs864745
###end p 47
###begin p 48
###xml 75 76 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 76 77 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 219 220 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 257 258 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 258 259 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
Data are medians (25% to 75% range) or means +/- SD (BMI, waist, and BIGTT-SI). Values of BMI, plasma glucose, serum insulin, and derived indices were logarithmically transformed before statistical analysis. Calculated P values were adjusted for age (BIGTT-SI and BIGTT-AIR), age and sex (BMI and waist), or age, sex, and BMI (all other traits), assuming an additive, dominant, or recessive model. Indices of insulin release and insulin sensitivity were calculated as described in research design and methods. 1, type 2 diabetes-protective allele; 2, diabetes-associated allele.
###end p 48
###begin p 49
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC123</italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK1D</italic>
Unadjusted quantitative metabolic traits in the population-based Inter99 cohort including 4,395 middle-aged subjects with normal glucose tolerance stratified according to genotype of CDC123/CAMK1D rs12779790
###end p 49
###begin p 50
###xml 74 75 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 75 76 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 218 219 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 256 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 257 258 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
Data are median (25% to 75% range) or means +/- SD (BMI, waist, and BIGTT-SI). Values of BMI, plasma glucose, serum insulin, and derived indices were logarithmically transformed before statistical analysis. Calculated P values were adjusted for age (BIGTT-SI and BIGTT-AIR), age and sex (BMI and waist), or age, sex, and BMI (all other traits), assuming an additive, dominant, or recessive model. Indices of insulin release and insulin sensitivity were calculated as described in research design and methods. 1, type 2 diabetes-protective allele; 2, diabetes-associated allele.
###end p 50
###begin p 51
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSPAN8</italic>
Unadjusted quantitative metabolic traits in the population-based Inter99 cohort including 4,410 middle-aged subjects with normal glucose tolerance stratified according to genotype of TSPAN8 rs7961581
###end p 51
###begin p 52
###xml 75 76 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 76 77 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 219 220 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 257 258 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 258 259 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
Data are medians (25% to 75% range) or means +/- SD (BMI, waist, and BIGTT-SI). Values of BMI, plasma glucose, serum insulin, and derived indices were logarithmically transformed before statistical analysis. Calculated P values were adjusted for age (BIGTT-SI and BIGTT-AIR), age and sex (BMI and waist), or age, sex, and BMI (all other traits), assuming an additive, dominant, or recessive model. Indices of insulin release and insulin sensitivity were calculated as described in research design and methods. 1, type 2 diabetes-protective allele; 2, diabetes-associated allele.
###end p 52

